Manulife (Manufacturers Life Insurance)
HARP

Manulife (Manufacturers Life Insurance)’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,204
Closed -$167K – 3244
2021
Q2 		$167K Buy
+1,204
New +$230K ﹤0.01% 3175

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s HARP Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2021, closing a stake of 1,204 shares — an estimated $167K sold.

Manulife (Manufacturers Life Insurance) first reported a position in HARP in Q2 2021 and held it in 1 quarter. The position peaked at $167K in Q2 2021. 93 funds tracked by Wall St. Rank hold HARP as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,204 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $167K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Manulife (Manufacturers Life Insurance)'s Harpoon Therapeutics, Inc. Common Stock position peaked at $167K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.